Phospholipase D activity in human platelets is inhibited by protein kinase A, involving inhibition of phospholipase D1 translocation

Platelets

Volumn 19, Issue 4, 2008, Pages 300-307

  Vorland, M ^a,b   Holmsen, H ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Phospholipase D; Platelets; Prostaglandin E1; Protein kinase A; Translocation

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENZYME ACTIVATOR; ENZYME INHIBITOR; FORSKOLIN; PHOSPHOLIPASE; PHOSPHOLIPASE D; PHOSPHOLIPASE D1; PROSTAGLANDIN E1; THROMBIN;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE;

ALPROSTADIL; BLOOD PLATELETS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FORSKOLIN; HUMANS; PHOSPHOLIPASE D; PLATELET ACTIVATION; PROTEIN TRANSPORT; THROMBIN;

EID: 45749114128     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100801910838     Document Type: Article

References (44)

1. Chiang TM. Activation of phospholipase D in human platelets by collagen and thrombin and its relationship to platelet aggregation. Biochim Biophys Acta 1994;1224:147-155.
2. Haslam RJ, Coorssen JR. Evidence that activation of phospholipase D can mediate secretion from permeabilized platelets. Adv Exp Med Biol 1993;344:149-164.
3. Kaul D. Lipoprotein receptor-Ck activation-response coupling in human platelets. Platelets 1995;6:306-309.
4. Kochhar N, Kaul D. Initiator-promoter coupling of phospholipases D and A2 in platelets upon cholesterol incorporation. FEBS Lett 1992;314:17-19.
5. Rubin R. Phosphatidylethanol formation in human platelets: Evidence for thrombin-induced activation of phospholipase D. Biochem Biophys Res Commun 1988;156:1090-1096.
6. Vorland M, Holmsen H. Phospholipase D in human platelets: Presence of isoenzymes and participation of autocrine stimulation during thrombin activation. Platelets 2008;19:211-224.
7. Ryningen A, Holmsen, H. Biochemistry of platelet activation, In: HRR Gundu, editor, Kluwer Academic Publishers, Inc, Norwell (MA), USA; 1998, pp 188-237.
8. Mills DC, Smith JB. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets. Biochem J 1971;121:185-96.
9. Holmsen H. classification and possible mechanisms of drugs that inhibit platelet aggregation. Ser Haematol 1976;8:50-80.
10. White RE, Kryman JP, El-Mowafy AM, Han G, Carrier GO. cAMP-dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate BK(Ca) channel activity in coronary artery smooth muscle cells. Circ Res 2000;86:897-905.
11. Kodaki T, Yamashita S. Cloning, expression, and characterization of a novel phospholipase D complementary DNA from rat brain. J Biol Chem 1997;272:11408-11413.
12. Colley WC, Sung TC, Roll R, Jenco J, Hammond SM, Altshuller Y, Bar-Sagi D, Morris AJ, Frohman MA. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol 1997;7:191-201.
13. Sung TC, Altshuller YM, Morris AJ, Frohman MA. Molecular analysis of mammalian phospholipase D2. J Biol Chem 1999;274:494-502.
14. Sciorra VA, Rudge SA, Prestwich GD, Frohman MA, Engebrecht J, Morris AJ. Identification of a phosphoinositide binding motif that mediates activation of mammalian and yeast phospholipase D isoenzymes. Embo J 1999;18:5911-5921.
15. Huang R, Kucera GL, Rittenhouse SE. Elevated cytosolic Ca2+ activates phospholipase D in human platelets. J Biol Chem 1991;266:1652-1655.
16. Martinson EA, Scheible S, Greinacher A, Presek P. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism. Biochem J 1995;310(Pt 2):623-628.
17. Martinson EA, Scheible S, Marx-Grunwitz A, Presek P. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Thromb Haemost 1998;80:976-981.
18. Martinson EA, Scheible S, Presek P. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors. Cell Mol Biol (Noisy-le-grand) 1994;40:627-634.
19. Nofer JR, Walter M, Kehrel B, Seedorf U, Assmann G. HDL3 activates phospholipase D in normal but not in glycoprotein IIb/IIIa-deficient platelets. Biochem Biophys Res Commun 1995;207:148-154.
20. Coorssen JR. Phospholipase activation and secretion: Evidence that PLA2, PLC, and PLD are not essential to exocytosis. Am J Physiol 1996;270(4 Pt 1):C1153-1163.
21. Coorssen JR, Haslam RJ. GTP gamma S and phorbol ester act synergistically to stimulate both Ca(2+)-independent secretion and phospholipase D activity in permeabilized human platelets. Inhibition by BAPTA and analogues. FEBS Lett 1993;316:170-174.
22. Jones D, Morgan C, Cockcroft S. Phospholipase D and membrane traffic. Potential roles in regulated exocytosis, membrane delivery and vesicle budding. Biochim Biophys Acta 1999;1439:229-244.
23. Liscovitch M CM, Fiucci G, Lavie Y, Tang X. Localization and possible functions of phospholipase D isozymes. Biochim Biophys Acta 1999;1439:245-263.
24. Nozawa Y. Roles of phospholipase D in apoptosis and pro-survival. Biochim Biophys Acta 2002;1585:77-86.
25. Tysnes OB, Aarbakke GM, Verhoeven AJ, Holmsen H. Thin-layer chromatography of polyphosphoinositides from platelet extracts: interference by an unknown phospholipid. Thromb Res 1985;40:329-338.
26. Lages B, Scrutton MC, Holmsen H. Studies on gel-filtered human platelets: isolation and characterization in a medium containing no added Ca2+, Mg2+, or K+. J Lab Clin Med 1975;85:811-825.
27. Martin TW. Formation of diacylglycerol by a phospholipase D-phosphatidate phosphatase pathway specific for phosphatidylcholine in endothelial cells. Biochim Biophys Acta 1988;962:282-296.
28. Ryningen A, Olav Jensen B, Holmsen H. Elevation of cyclic AMP decreases phosphoinositide turnover and inhibits thrombin-induced secretion in human platelets. Biochim Biophys Acta 1998;1394:235-248.
29. Ryningen A, Holmsen H. Role of autocrine stimulation for the effects of cyclic AMP on protein and lipid phosphorylation in platelets activated by particles. FEBS Lett 1998;436:335-338.
30. Jensen BO, Selheim F, Doskeland SO, Gear AR, Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood 2004;104:2775-2782.
31. Wu H, James-Kracke MR, Halenda SP. Direct relationship between intracellular calcium mobilization and phospholipase D activation in prostaglandin E-stimulated human erythroleukemia cells. Biochemistry 1992;31:3370-3377.
32. Wu H, Turner JT, Halenda SP. Activation of phospholipase D by E-series prostaglandins in human erythroleukemia cells. J Pharmacol Exp Ther 1991;258:607-612.
33. Choi WS, Chahdi A, Kim YM, Fraundorfer PF, Beaven MA. Regulation of phospholipase D and secretion in mast cells by protein kinase A and other protein kinases. Ann N Y Acad Sci 2002;968:198-212.
34. Jang MJ, Lee MJ, Park HY, Bae YS, Min do S, Ryu SH, Kwak JY. Phosphorylation of phospholipase D1 and the modulation of its interaction with RhoA by cAMP-dependent protein kinase. Exp Mol Med 2004;36:172-178.
35. Mamoon AM, Smith J, Baker RC, Farley JM. Activation of protein kinase A increases phospholipase D activity and inhibits phospholipase D activation by acetylcholine in tracheal smooth muscle. J Pharmacol Exp Ther 1999;291:1188-1195.
36. Cohen G, Rubinstein S, Gur Y, Breitbart H. Crosstalk between protein kinase A and C regulates phospholipase D and F-actin formation during sperm capacitation. Dev Biol 2004;267:230-241.
37. Exton JH. Regulation of phospholipase D. FEBS Lett 2002;531:58-61.
38. Steen VM, Holmsen H. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: Comparison of aggregation and shape change. Thromb Haemost 1984;52:333-335.
39. Tysnes OB, Steen VM, Frolich KW, Holmsen H. Evidence that chlorpromazine and prostaglandin E1 but not neomycin interfere with the inositol phospholipid metabolism in intact human platelets. FEBS Lett 1990;264:33-36.
40. de Chaffoy de Courcelles D, Roevens P, Van Belle H. Prostaglandin E1 and forskolin antagonize C-kinase activation in the human platelet. Biochem J 1987;244:93-99.
41. Thorsen VA, Vorland M, Bjorndal B, Bruland O, Holmsen H, Lillehaug JR. Participation of phospholipase D and alpha/beta-protein kinase C in growth factor-induced signalling in C3H10T1/2 fibroblasts. Biochim Biophys Acta 2003;1632:62-71.
42. Becker KP, Hannun YA. Protein kinase C and phospholipase D: Intimate interactions in intracellular signaling. Cell Mol Life Sci 2005;62:1448-1461.
43. Hu T, Exton JH. Mechanisms of regulation of phospholipase D1 by protein kinase Calpha. J Biol Chem 2003;278:2348-2355.
44. Chen J-S, Exton JH. Regulation of phospholipase D2 activity by protein kinase C{alpha}. J Biol Chem 2004;279:22076-22083.